CellEcho

CellEcho is an Irvine, California-based biotechnology company developing a revolutionary AI-integrated platform for accelerating cell therapy design, build, test, and learn.

We address a critical bottleneck in the cell therapy field – the slow and costly iteration cycle – by automating the process and leveraging artificial intelligence. Our platform dramatically reduces development timelines, moving from months to days, allowing researchers to explore and optimize cell therapies with unprecedented speed and efficiency.

CellEcho’s core technology, a fully automated platform, is transforming the landscape of immunooncology, regenerative medicine, and other cell therapy applications. We are building the world’s fastest, smartest engine for creating living medicines, ultimately improving patient outcomes and accelerating the delivery of life-saving treatments.

Founded in 2021, CellEcho Biotech is comprised of a dedicated team focused on pioneering advancements in cell engineering and cell therapy automation.